Eli Lilly | LLY - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 695M 1.12B 2026-03
Abbott USD 1.08B 699M 2026-03
ALKERMES USD -66.48M 115.82M 2026-03
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Baxter International USD -15M 1.11B 2026-03
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merck USD -4.24B 7.2B 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Perrigo USD -398.6M 1.02B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Sanofi EUR -801M 3.6B 2025-12
United Therapeutics USD 274.9M 89.4M 2026-03
Zoetis USD 601M 2M 2026-03